{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:57:38Z","timestamp":1781020658389,"version":"3.54.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,9]]},"DOI":"10.7759\/cureus.110527","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:13:19Z","timestamp":1781017999000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Hyperlipidemia and Multifocal Atherosclerosis With Negative Genetic Testing for Familial Hypercholesterolemia: A Case Report"],"prefix":"10.7759","author":[{"given":"Dawid","family":"Buczy\u0144ski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"R\u00f3g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Pa\u0142ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Susu\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Rajtar-Salwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard BG","year":"2013","unstructured":"Nordestgaard BG, Chapman MJ, Humphries SE, et al.. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013, 34:3478-90a. 10.1093\/eurheartj\/eht273","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach F","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al.. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020, 41:111-88. 10.1093\/eurheartj\/ehz455","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2009.10.014","article-title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip","volume":"85","author":"Talmud PJ","year":"2009","unstructured":"Talmud PJ, Drenos F, Shah S, et al.. Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Am J Hum Genet. 2009, 85:628-42. 10.1016\/j.ajhg.2009.10.014","journal-title":"Am J Hum Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5114\/aoms\/141941","article-title":"PoLA\/CFPiP\/PCS\/PSLD\/PSD\/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021","volume":"17","author":"Banach M","year":"2021","unstructured":"Banach M, Burchardt P, Chlebus K, et al.. PoLA\/CFPiP\/PCS\/PSLD\/PSD\/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021. Arch Med Sci. 2021, 17:1447-547. 10.5114\/aoms\/141941","journal-title":"Arch Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14744\/AnatolJCardiol.2019.95038","article-title":"Molecular diagnosis methods in familial hypercholesterolemia","volume":"23","author":"Moldovan V","year":"2020","unstructured":"Moldovan V, Banescu C, Dobreanu M. Molecular diagnosis methods in familial hypercholesterolemia. Anatol J Cardiol. 2020, 23:120-7. 10.14744\/AnatolJCardiol.2019.95038","journal-title":"Anatol J Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards S","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al.. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015, 17:405-24. 10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.16417","article-title":"Targeted sequencing of a gene panel in patients with familial hypercholesterolemia from Southern Poland","volume":"133","author":"Toto\u0144-\u017bura\u0144ska J","year":"2023","unstructured":"Toto\u0144-\u017bura\u0144ska J, Wo\u0142kow P, Kapusta M, et al.. Targeted sequencing of a gene panel in patients with familial hypercholesterolemia from Southern Poland. Pol Arch Intern Med. 2023, 133:10.20452\/pamw.16417","journal-title":"Pol Arch Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.07.752","article-title":"Optimizing cholesterol treatment in patients with muscle complaints","volume":"70","author":"Rosenson RS","year":"2017","unstructured":"Rosenson RS, Baker S, Banach M, et al.. Optimizing cholesterol treatment in patients with muscle complaints. J Am Coll Cardiol. 2017, 70:1290-301. 10.1016\/j.jacc.2017.07.752","journal-title":"J Am Coll Cardiol"},{"key":"ref9","unstructured":"Announcement of the Minister of Health of 18 March 2024 on the list of reimbursed drugs, foodstuffs for particular nutritional uses and medical devices effective as of 1 April 2024 [In Polish]. (2024). Accessed. May 5, 2026: https:\/\/www.gov.pl\/web\/zdrowie\/obwieszczenie-ministra-zdrowia-z-dnia-18-marca-2024-r-w-sprawie-wykazu-refundowanych-l...."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine MS","year":"2017","unstructured":"Sabatine MS, Giugliano RP, Keech AC, et al.. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017, 376:1713-22. 10.1056\/NEJMoa1615664","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/494125-severe-hyperlipidemia-and-multifocal-atherosclerosis-with-negative-genetic-testing-for-familial-hypercholesterolemia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:13:21Z","timestamp":1781018001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/494125-severe-hyperlipidemia-and-multifocal-atherosclerosis-with-negative-genetic-testing-for-familial-hypercholesterolemia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.110527","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,9]]}}}